{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:22:08Z","timestamp":1790050928639,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010137","name":"Fondation Sanofi Espoir","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010156","name":"Netherlands Leprosy Relief","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xkme.2023.100622","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T16:45:46Z","timestamp":1678121146000},"page":"100622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-0735","authenticated-orcid":false,"given":"Nancy L.","family":"Reaven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 suppl 1","key":"10.1016\/j.xkme.2023.100622_bib1","first-page":"S1","article-title":"US Renal Data System. 2019 Annual Data Report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2023.100622_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2369-15-55","article-title":"Metabolic acidosis and the progression of chronic kidney disease","volume":"15","author":"Chen","year":"2014","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100622_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: A report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.xkme.2023.100622_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","article-title":"Mechanisms of muscle wasting in chronic kidney disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100622_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12882-021-02385-z","article-title":"Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: An observational cohort study","volume":"22","author":"Tangri","year":"2021","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100622_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.xkme.2021.04.011","article-title":"Metabolic acidosis and cardiovascular disease in CKD","volume":"3","author":"Collister","year":"2021","journal-title":"Kidney Med"},{"issue":"10 Suppl","key":"10.1016\/j.xkme.2023.100622_bib7","first-page":"S163","article-title":"All-cause costs increase exponentially with increased chronic kidney disease stage","volume":"23","author":"Golestaneh","year":"2017","journal-title":"Am J Manag Care"},{"issue":"7","key":"10.1016\/j.xkme.2023.100622_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"10.1016\/j.xkme.2023.100622_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0002-9343(00)00371-5","article-title":"A\u00a0simple comorbidity scale predicts clinical outcomes and costs in dialysis patients","volume":"108","author":"Beddhu","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.xkme.2023.100622_bib10","series-title":"Encyclopedia of Statistical Sciences","first-page":"5","article-title":"Trimming and winsorization","author":"Ruppert","year":"2006"},{"issue":"3 suppl 1","key":"10.1016\/j.xkme.2023.100622_bib11","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System. 2018 Annual Data Report: Epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.xkme.2023.100622_bib12","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1681\/ASN.2010111181","article-title":"Estimated GFR, albuminuria, and complications of chronic kidney disease","volume":"22","author":"Inker","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100622_bib13","first-page":"40","article-title":"Longitudinal study of chronic kidney disease progression and associated costs","volume":"3","author":"Golestaneh","year":"2017","journal-title":"J Clin Pathways"},{"issue":"5","key":"10.1016\/j.xkme.2023.100622_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/01.ASN.0000125670.64996.BB","article-title":"Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population","volume":"15","author":"Smith","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100622_bib15","first-page":"447","article-title":"The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes","volume":"22","author":"Lage","year":"2019","journal-title":"J\u00a0Med Econ"},{"issue":"11","key":"10.1016\/j.xkme.2023.100622_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:25:20Z","timestamp":1762910720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2590059523000316"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100622","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100622"}}